Llwytho...
New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
The relapse rate for children with acute myeloid leukemia (AML) remains high despite advancements in risk classification, multi-agent chemotherapy intensification, stem cell transplantation, and supportive care guidelines. Prognosis for this subgroup of children with relapsed/refractory AML remains...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Children (Basel) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072702/ https://ncbi.nlm.nih.gov/pubmed/32050659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/children7020012 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|